United States
Germany
Japan
United Kingdom
China
EGR2 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Proteins
TCF7 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
WT1 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
RAB1B HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
ELL2 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
KAT5 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
TBX1 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
ZNF689 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
FOXP2 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
POU3F2 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
EZH2 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
KDM1A HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
FOXM1 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
DACH1 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
活动过滤器
优化搜索结果
Species
Target Symbol
- P53 (5)
- FOXO3 (4)
- CALRETICULIN (3)
- ESTROGEN RECEPTOR 1 (3)
- OCT4 (3)
- SATB1 (3)
- SOX2 (3)
- AMINO TERMINAL ENHANCER OF SPLIT (2)
- AP2 ALPHA (2)
- BETA CATENIN (2)
- C-MYC (2)
- CRABP2 (2)
- DNMT1 (2)
- DYNAMIN 2 (2)
- E2F1 (2)
- EZH2 (2)
- FOXO1 (2)
- GATA3 (2)
- HIF1 BETA (2)
- HNF 4 ALPHA (2)
- IRF8 (2)
- JUNB (2)
- KDM1A (2)
- KEAP1 (2)
- MAX (2)
- MCM7 (2)
- NONO (2)
- P63 (2)
- RUNX1 (2)
- SAM68 (2)
- SATB2 (2)
- SIRT1 (2)
- SIRT7 (2)
- SMAD4 (2)
- SOX4 (2)
- SOX9 (2)
- STAT3 (2)
- TNF ALPHA (2)
- VON HIPPEL LINDAU (2)
- YB1 (2)
- ZSCAN4 (2)
- AP2 GAMMA (1)
- APE1 (1)
- BACH2 (1)
- BCL 6 (1)
- BMI1 (1)
- BORIS (1)
- C-MYB (1)
- CAVIN1 (1)
- CBL (1)
- CEBP BETA (1)
- CITED2 (1)
- CREB3L1 (1)
- CREB3L2 (1)
- CREG1 (1)
- DACH1 (1)
- DAXX (1)
- E2F4 (1)
- EGR2 (1)
- ELL2 (1)
- ENPP2 (1)
- ERG (1)
- ESTROGEN RECEPTOR BETA (1)
- ESTROGEN RELATED RECEPTOR GAMMA (1)
- ETS1 ASSOCIATED PROTEIN II (1)
- ETS2 (1)
- ETV7 (1)
- EWSR1 (1)
- FOXC1 (1)
- FOXM1 (1)
- FOXP1 (1)
- FOXP2 (1)
- FOXP3 (1)
- FUBP1 (1)
- FUSIP1 (1)
- GLI1 (1)
- HDAC2 (1)
- HDAC4 (1)
- HDAC6 (1)
- HDAC7 (1)
- HDAC8 (1)
- HES1 (1)
- HIF-1 ALPHA (1)
- HNRNPD (1)
- HOXB13 (1)
- HOXB5 (1)
- ID3 (1)
- IFI16 (1)
- IKAROS (1)
- IKK BETA (1)
- IRF1 (1)
- IRF5 (1)
- JAB1 (1)
- KAP1 (1)
- KAT5 (1)
- KLF4 (1)
- KU70 (1)
- LEF1 (1)
- LMO4 (1)
- LXR ALPHA (1)
Applications
Brands
QC Levels
Pathways
- Pathways in cancer (43)
- Chronic myeloid leukemia (21)
- MAPK signaling pathway (20)
- Prostate cancer (19)
- Cell cycle (18)
- Pancreatic cancer (17)
- Wnt signaling pathway (16)
- Colorectal cancer (15)
- Endometrial cancer (15)
- Small cell lung cancer (15)
- Thyroid cancer (14)
- Neurotrophin signaling pathway (13)
- Acute myeloid leukemia (12)
- Chemokine signaling pathway (12)
- Non-small cell lung cancer (12)
- TGF-beta signaling pathway (12)
- Apoptosis (11)
- Basal cell carcinoma (10)
- Bladder cancer (10)
- Huntington's disease (9)
- Melanoma (9)
- Adherens junction (8)
- Adipocytokine signaling pathway (8)
- Amyotrophic lateral sclerosis (ALS) (8)
- Glioma (8)
- Jak-STAT signaling pathway (7)
- Melanogenesis (7)
- T cell receptor signaling pathway (7)
- Toll-like receptor signaling pathway (7)
- Ubiquitin mediated proteolysis (7)
- Endocytosis (6)
- RIG-I-like receptor signaling pathway (6)
- Renal cell carcinoma (6)
- p53 signaling pathway (6)
- ErbB signaling pathway (5)
- Insulin signaling pathway (5)
- Maturity onset diabetes of the young (5)
- NOD-like receptor signaling pathway (5)
- Antigen processing and presentation (4)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (4)
- B cell receptor signaling pathway (4)
- Type II diabetes mellitus (4)
- Allograft rejection (3)
- Cytokine-cytokine receptor interaction (3)
- Cytosolic DNA-sensing pathway (3)
- Dilated cardiomyopathy (3)
- Epithelial cell signaling in Helicobacter pylori infection (3)
- Fc epsilon RI signaling pathway (3)
- Fc gamma R-mediated phagocytosis (3)
- Focal adhesion (3)
- Graft-versus-host disease (3)
- Hypertrophic cardiomyopathy (HCM) (3)
- Leukocyte transendothelial migration (3)
- Metabolic pathways (3)
- Natural killer cell mediated cytotoxicity (3)
- Notch signaling pathway (3)
- PPAR signaling pathway (3)
- Tight junction (3)
- Type I diabetes mellitus (3)
- Alzheimer's disease (2)
- Asthma (2)
- Base excision repair (2)
- Cysteine and methionine metabolism (2)
- DNA replication (2)
- Dorso-ventral axis formation (2)
- Hematopoietic cell lineage (2)
- Oocyte meiosis (2)
- Pathogenic Escherichia coli infection (2)
- Systemic lupus erythematosus (2)
- Autoimmune thyroid disease (1)
- Basal transcription factors (1)
- Cell adhesion molecules (CAMs) (1)
- Ether lipid metabolism (1)
- Hedgehog signaling pathway (1)
- Long-term depression (1)
- Non-homologous end-joining (1)
- Progesterone-mediated oocyte maturation (1)
- RNA degradation (1)
- Regulation of actin cytoskeleton (1)
- Spliceosome (1)
- Viral myocarditis (1)
- mTOR signaling pathway (1)
